Oxygenta Pharmaceutical Ltd — Insider Trade, 30-06-2025: Insider Trading / SAST

Oxygenta Pharmaceutical Limited has announced a trading window closure for all designated persons and their immediate relatives starting July 1, 2025, until 48 hours after the announcement of the financial results for the quarter. This measure is to ensure compliance with insider trading regulations and to maintain market integrity ahead of the financial results release. The board meeting date for discussing these results will be shared later. This impacts stakeholders by reinforcing transparency in the company’s securities trading around key financial updates.